[1]GOLD Executive Committee,GOLD Science Committee. Glo-bal strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease(Revised 2011)[S/OL]. Bethesda(USA):GOLD Executive Committee,2011[2013-03-02]. http://www. goldcopd. com. [2]柳涛,蔡柏蔷. 慢性阻塞性肺疾病诊断、处理和预防全球策略(2011 年修订版)介绍. 中国呼吸与危重监护杂志,2012,11(1):1-12. [3]文富强,贺蓓. 慢性阻塞性肺疾病全球创议(2011年修订版)解读. 中华医学杂志,2012,92(14):937-938. [4]沈宁,姚婉贞. 关注2011年版慢性阻塞性肺疾病全球创议. 中华结核和呼吸杂志,2012,35(1):6. [5]常春,贺蓓. 对欧美四学会关于稳定期慢性阻塞性肺疾病诊疗指南2011年更新版的介绍. 中华结核和呼吸杂志,2012,35(4):256-258. [6]Soriano JB,Alfageme I,Almagro P,et al. Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest,2013,143(3):694-702. [7]Leidy NK,Wilcox TK,Jones PW,et al. Development of the exacerbations of chronic obstructive pulmonary disease tool(EXACT):a patient-reported outcome(PRO)measure. Value Health,2010,13(8):965-975. [8]Gruffydd-Jones K. GOLD guidelines 2011:what are the impli-cations for primary care? Prim Care Respir J,2012,21(4):437-441. [9]冯玉麟,王岚. 中国COPD防治的难题. 中国呼吸与危重监护杂志,2012,11(4):313-316. [10]GOLD Executive Committee,GOLD Science Committee. Glo-bal strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease(Upadted 2013)[S/OL]. Bethesda(USA):GOLD Executive Committee,2013[2013-03-02]. http://www. goldcopd. com. |